Johanna Melo-Cardenas, PhD
Dr. Melo-Cardenas has been awarded a grant focused on studying alterations in large cells in the bone marrow called megakaryocytes, and exploring how changes in the bone marrow microenvironment contribute to disease progression in primary myelofibrosis, a blood cancer characterized by a buildup of fibrous tissue that impairs the bone marrow’s ability to produce normal blood cells.
Content courtesy of Leukemia & Lymphoma Society